期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Management of major vascular injury in laparoscopic urology
1
作者 Sheng Cheng Qiming Zheng +3 位作者 Liwei Xu weiping zhao Gonghui Li Guoqing Ding 《Laparoscopic, Endoscopic and Robotic Surgery》 2020年第4期107-110,共4页
Objective:During the past three decades,laparoscopy has played a significant role in the management of urological disorders.This study aims to standardize the management of major vascular injury,which is a life-threat... Objective:During the past three decades,laparoscopy has played a significant role in the management of urological disorders.This study aims to standardize the management of major vascular injury,which is a life-threatening complication in the laparoscopic urological procedures.Methods:A total of 8210 patients with the urological disorder,who underwent laparoscopic surgery at Sir Run Run Shaw Hospital from January 2000 to December 2018,were included in this retrospective study.Patients’data of the laparoscopic major vascular injury were collected and analyzed,and the basic principles of the procedure were summarized.Results:A total of 15(0.18%)cases of major vascular injury were found among the 8210 patients,and 2 of them were converted to open surgery.Although the type of laparoscopic surgery,causes,and management of major vascular injury among the patients were diverse,the main management strategies of major vascular injury in laparoscopic surgery were to keep the vision clear,control bleeding rapidly by clamping and compression,make full preparation for possibly needed liquid resuscitation,and try best to repair under laparoscope.If necessary,converse to open surgery.Conclusion:Although the reported incidence of major vascular injury in laparoscopic urological surgery is extremely low,such injury can result in high morbidity and mortality.It is important to rapidly identify the cause and strictly follow the standardized management for better outcomes. 展开更多
关键词 Laparoscopic urology Major vascular injury MANAGEMENT
下载PDF
基于网络药理学和代谢组学分析滁菊中潜在活性成分及其药理作用机制 被引量:2
2
作者 赵维萍 葛奇 +4 位作者 丁子俊 潘雷枝 谷子晴 刘洋 蔡华 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第6期412-428,共17页
“滁菊”是我国著名的传统中药材,它含有多种有效活性成分,可以治疗多种疾病,而且没有毒副作用。为了进一步探究“滁菊”中的有效活性成分及其作用靶点和药理机制,本研究采用代谢组学与网络药理学相结合的方法,构建了基于化学、药代动... “滁菊”是我国著名的传统中药材,它含有多种有效活性成分,可以治疗多种疾病,而且没有毒副作用。为了进一步探究“滁菊”中的有效活性成分及其作用靶点和药理机制,本研究采用代谢组学与网络药理学相结合的方法,构建了基于化学、药代动力学和药理学的可视化网络分析模型,对滁菊的潜在药理机制进行了预测。共鉴定出424个代谢产物,通过ADME筛选出21个具有潜在药用活性成分的化合物。对活性成分进一步的药理学分析发现,滁菊中的金合花素、β-谷甾醇通过作用于GSK3B、MAPK14、ADRA1R和NOS2等靶点蛋白来调控糖尿病、阿尔茨海默病、乳腺癌和炎症等疾病。这些结果成功地说明了“滁菊”潜在的有效活性成分具有多种药理作用机制。 展开更多
关键词 滁菊 代谢组学 网络药理学 抗癌 抗糖尿病
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部